?>
Quantisnow

EXL Recognized as Market Leader in HFS Research Insurance Services Report

Quantisnow democratizes market-moving insights for retail traders.

Quantisnow

Actuate Therapeutics To Collaborate with Incyte Corporation and the University of Pittsburgh on Clinical Trial of Elraglusib in Combination with Retifanlimab and mFOLFIRINOX in Patients with Advanced Pancreatic Cancer

Quantisnow democratizes market-moving insights for retail traders.

Quantisnow

Cingulate Submits New Drug Application to FDA for Lead ADHD Asset CTx-1301

Quantisnow democratizes market-moving insights for retail traders.

Quantisnow

Wearable Devices Announces Development of Neural Interface for Advanced Military Tactical Systems

Quantisnow democratizes market-moving insights for retail traders.

Quantisnow

Pinnacle West Reports Lower 2025 Second-Quarter Financial Results Compared to a Year Ago

Quantisnow democratizes market-moving insights for retail traders.

Quantisnow

Blink Charging Reschedules Release of Second Quarter 2025 Results and Conference Call to August 18

Quantisnow democratizes market-moving insights for retail traders.

Quantisnow

Moleculin Biotech, Inc. Unveils Promising Preclinical Data of Annamycin in Liver Cancer Treatment

Quantisnow democratizes market-moving insights for retail traders.

Quantisnow

Flotek Industries upgraded by Northland Capital with a new price target

Quantisnow democratizes market-moving insights for retail traders.

Quantisnow

Ollie's Highlights Exclusive Shopper Survey Results Ahead of National Bargain Hunting Week

Quantisnow democratizes market-moving insights for retail traders.

Quantisnow

XPEL Reports Record Revenue of $124.7 Million; Revenue Growth of 13.5% in Second Quarter 2025

Quantisnow democratizes market-moving insights for retail traders.

Quantisnow

SeaStar Medical Reaches New Enrollment Milestone in NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury (AKI)

Quantisnow democratizes market-moving insights for retail traders.

Quantisnow

MetaVia Extends 48 mg MAD Portion of Its Phase 1 Clinical Trial of DA-1726 for the Treatment of Obesity to 8 Weeks and Announces Fifth Weekly Dose in First Patient

Quantisnow democratizes market-moving insights for retail traders.

Quantisnow

EVENTS.COM AND SUMMIT MERGE TO CREATE A POWERFUL PLATFORM THAT EXPANDS THE GLOBAL CREATIVE BUSINESS ECONOMY

Quantisnow democratizes market-moving insights for retail traders.

Quantisnow

Benchmark Publishes Update Note on TNL Mediagene (NASDAQ: TNMG), Highlighting Recent Strategic Developments at the Company and Maintaining the $3.50 Price Target

Quantisnow democratizes market-moving insights for retail traders.

Quantisnow

AI, Robotics Are Reshaping the Future of Hospitality

Quantisnow democratizes market-moving insights for retail traders.

Quantisnow

LivePerson Announces Expanded Partnership with Google Cloud to Transform Enterprise AI Outcomes and Customer Experience

Quantisnow democratizes market-moving insights for retail traders.

Quantisnow

Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators

Quantisnow democratizes market-moving insights for retail traders.

Quantisnow

Caris Life Sciences Publishes Study Showing AI Signature-positive Breast Cancer Patients Live Almost Twice as Long as AI-negative Patients When Treated with a Checkpoint Inhibitor

Quantisnow democratizes market-moving insights for retail traders.

Quantisnow

WEIS MARKETS REPORTS SECOND QUARTER 2025 RESULTS

Quantisnow democratizes market-moving insights for retail traders.

Quantisnow

Health Economic Study Shows That enVVeno Medical's VenoValve(R) Would be a Cost-Effective Treatment Option for Patients with Severe Chronic Venous Insufficiency

Quantisnow democratizes market-moving insights for retail traders.

Quantisnow

Ondas Holdings to Report Second Quarter 2025 Financial Results on August 12, 2025, at 8:30 a.m. ET

Quantisnow democratizes market-moving insights for retail traders.

Quantisnow

Lantern Pharma's Subsidiary, Starlight Therapeutics, Announces U.S. Food and Drug Administration Clearance of IND for Phase Ib/2a Glioblastoma Multiforme (GBM) Trial

Quantisnow democratizes market-moving insights for retail traders.

Quantisnow

Energy Transfer Announces Natural Gas Pipeline Project to Serve Growing Southwestern U.S. Markets

Quantisnow democratizes market-moving insights for retail traders.

Quantisnow

Trump Media Begins Public Beta Testing AI Search Engine

Quantisnow democratizes market-moving insights for retail traders.

Quantisnow

Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology

Quantisnow democratizes market-moving insights for retail traders.